Laurus Labs management sees a clear pathway for further margin expansion as the company continue delivering on mid-late phase ...

New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...

Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led ...

As respiratory illnesses like COVID-19, influenza, and Mycoplasma pneumonia continue to spread, the need for s ...

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

In the first five months of 2025, 305 samples of a wide range of drugs – including lifesaving medication – drawn from ...

The US has also put up a Strategic National Stockpile (SNS) initially established in 1999 (then called the National Pharmaceutical Stockpile), that holds a broad range of emergency medicines — ...

I was just a baby scientist when I discovered the hormone that made Ozempic possible. I had no idea how life-changing—and world-changing—that ...

He pointed to the lack of any public action by the FDA to address repeated findings by independent labs — including by the U.S. Anti-Doping Agency in June 2012, and various teams of ...

Rocket Lab Corporation is headed for more upside in H2 on neutron and new deals pipeline. Click here to find out why RKLB ...

Royalty Pharma will pay up to $2 billion to Revolution Medicines to support the development and sales of an experimental drug ...

Pharma stocks: The rise in the pharma stocks comes on the back of easing global trade tensions, with US President Donald Trump announcing that the trade deal between US and China is "done".